LKL International Bhd (XKLS:0182) EBIT: RM-26.86 Mil (TTM As of Mar. 2026)


What is LKL International Bhd EBIT?

LKL International Bhd XKLS:0182 EBIT is RM-26.86 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

LKL International Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM-3.76 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM-26.86 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. LKL International Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was -10.96%. LKL International Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -18.62%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. LKL International Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -56.89%.

LKL International Bhd  (XKLS:0182) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

LKL International Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-16.256 * ( 1 - 0% )/( (154.306 + 142.224)/ 2 )
=-16.256/148.265
=-10.96 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=160.81 - 2.796 - ( 15.224 - max(0, 37.23 - 40.938+15.224))
=154.306

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=152.185 - 8.069 - ( 9.553 - max(0, 32.517 - 34.409+9.553))
=142.224

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

LKL International Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-15.024/( ( (64.747 + max(19.105, 0)) + (63.95 + max(13.558, 0)) )/ 2 )
=-15.024/( ( 83.852 + 77.508 )/ 2 )
=-15.024/80.68
=-18.62 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.79 + 12.89 + 4.817) - (2.796 + 0 + 3.596)
=19.105

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.88 + 14.863 + 0.88399999999999) - (8.069 + 0 + 0)
=13.558

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

LKL International Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-26.86/47.211
=-56.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LKL International Bhd EBIT Related Terms

LKL International Bhd EBIT Historical Data

* Premium members only.

The historical data trend for LKL International Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LKL International Bhd EBIT Chart

LKL International Bhd Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Sep22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.97 0.59 -2.21 -42.09 -24.01

LKL International Bhd Quarterly Data
Oct20 Jan21 Jul21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.99 -9.00 2.62 -16.72 -3.76

XKLS:0182 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, LKL International Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LKL International Bhd EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LKL International Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LKL International Bhd's EV-to-EBIT falls into.


LKL International Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-26.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM-26.86 Mil mean?
LKL International Bhd (XKLS:0182) has a EBIT of RM-26.86 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on LKL International Bhd.
Is LKL International Bhd's EBIT too high?
LKL International Bhd's current EBIT is RM-26.86 Mil.
How does LKL International Bhd's EBIT compare to ISRG and BDX?
LKL International Bhd's EBIT of RM-26.86 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on LKL International Bhd. LKL International Bhd's current EBIT is RM-26.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LKL International Bhd stock overvalued right now?
Based on GuruFocus' analysis, LKL International Bhd (XKLS:0182) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.05, compared to a current price of RM0.04 — trading 30% below its estimated fair value. The current EBIT is RM-26.86 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For LKL International Bhd (XKLS:0182), the current EBIT is RM-26.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LKL International Bhd Business Description

Address Wisma LKL, No.3, Jalan BS 7/18, Kawasan Perindustrian Bukit Serdang, Seksyen 7, Seri Kembangan, SGR, MYS, 43300
LKL International Bhd is engaged in the manufacturing of medical/healthcare beds, medical peripherals and accessories as well as trading of medical furniture, medical devices, personal protective equipment, medical peripherals and accessories. The company's operating segments are Manufacturing, Trading, Retail, and Investment Holding. The Manufacturing segment is involved in the manufacturing of medical and healthcare beds, medical peripherals, and accessories, and the Trading segment is involved in the trading of medical peripherals and accessories. The company serves its products to various end users such as hospitals and medical centers, as well as other healthcare-related facilities, including clinics and specialist institutions. The majority of revenue is earned from Malaysia.